N
GLSI icon

Nuveen’s Greenwich LifeSciences GLSI Stock Holding History

Nuveen’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.13M Buy
+88,717
New +$2.31M ﹤0.01% 2254
2022
Q2 		– Sell
-9,575
Closed -$206K – 3342
2022
Q1 		$206K Hold
9,575
– – ﹤0.01% 3189
2021
Q4 		$264K Hold
9,575
– – ﹤0.01% 3196
2021
Q3 		$403K Buy
9,575
+3,183
+50% +$133K ﹤0.01% 3206
2021
Q2 		$287K Buy
+6,392
New +$242K ﹤0.01% 3223

Other funds holding GLSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Nuveen's GLSI Position: Q1 2026 in Review

Nuveen opened a new position in Greenwich LifeSciences (GLSI) in Q1 2026: 88,717 shares worth $2.13M. The stake represents ﹤0.01% of the portfolio and ranks #2254 among its holdings. This is a return to the name: Nuveen previously reported a position in GLSI as recently as Q1 2022.

Nuveen first reported a position in GLSI in Q2 2021 and has held it in 5 quarters since. 64 funds tracked by Wall St. Rank hold GLSI as of Q1 2026.

  • Nuveen held 88,717 shares of Greenwich LifeSciences worth $2.13M as of Q1 2026.
  • Greenwich LifeSciences was a new Nuveen position in Q1 2026.
  • Greenwich LifeSciences made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #2254 holding.
  • Nuveen first reported a position in Greenwich LifeSciences in Q2 2021 and has held it in 5 quarters since.
  • 64 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.